The University of Oxford and the Serum Institute of India (SII) have started the world's first human trial of a vaccine ...
Pune: The Serum Institute of India (SII) has dispatched 4,000 investigational doses of a newly manufactured Ebola vaccine ...
The Print on MSN
Century after last TB vaccine, India’s Serum Institute partners with Gates MRI for novel jab
Tuberculosis remains world’s deadliest infectious disease despite being preventable and curable. Around 1.23 million of 10.7 ...
India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under ...
Serum Institute will invest over US$100 million to manufacture the M72/AS01E vaccine if approved, a breakthrough that could become the world's first new tuberculosis vaccine in more than a century. In ...
Serum Institute of India has partnered with Gates Medical Research Institute to manufacture M72/AS01E, a tuberculosis vaccine ...
A new TB vaccine could be the biggest breakthrough in over 100 years. The Serum Institute of India (SII) will manufacture the ...
The Serum Institute of India has supplied 4,000 investigational doses for the Phase I study.
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on. Benchmark your ...
Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results